The largest database of trusted experimental protocols

Mission lentiviral transduction particles plko 1 puro cmv turbogfp

Manufactured by Merck Group
Sourced in United States

The MISSION Lentiviral Transduction Particles pLKO.1-puro-CMV-TurboGFP are a set of lentiviral particles designed for the delivery and expression of a TurboGFP reporter gene in target cells. The particles contain a pLKO.1-puro-CMV-TurboGFP construct, which includes a puromycin resistance gene and a TurboGFP reporter gene under the control of the CMV promoter.

Automatically generated - may contain errors

2 protocols using mission lentiviral transduction particles plko 1 puro cmv turbogfp

1

Lentiviral-Mediated FUT8 Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
Next, 96-well plates containing 1.6 × 104 cells were freshly seeded and incubated overnight in a humidified incubator at 37 °C and 5% CO2 atmosphere. Lentiviral particles containing pLKO.1 plasmids targeting human FUT8 (MISSION Lentiviral Transduction Particles pLKO.1-puro-CMV-TurboGFP, TRCN0000035952, TRCN0000035953, TRCN00000229959, TRCN00000229960, and TRCN00000229961) and a non-targeting control (MISSION® pLKO.1-puro-CMV-TurboGFP, SHC003) were purchased from Sigma–Aldrich (St. Louis, MO, USA) (Supplementary Table S1). Briefly, 110 μL/well of hexadimethrine bromide (Sigma–Aldrich, St. Louis, MO, USA), at a final concentration of 8 μg/mL, and 15 μL/well of lentiviral particles were added ab initio. The cells were then incubated overnight, to allow transfection. Afterwards, DMEM was removed and replaced with fresh DMEM containing 5 μg/mL of puromycin. This medium was replaced every 72 h until resistant clones grew.
+ Open protocol
+ Expand
2

FUT8 Knockdown and Phenotypic Selection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell model employed in this work was developed previously by our research group [41 (link)]. Briefly, 96-well plates containing 1.6 × 104 cells were seeded and incubated overnight at 37 °C in an atmosphere of 5% CO2 in a humidified incubator. Next, 110 μL/well of hexadimethrine bromide (Sigma-Aldrich) at a final concentration of 8 μg/mL and 15 μL/well of two lentiviral particles from Sigma-Aldrich containing pLKO.1 plasmids targeting human FUT8 (MISSION lentiviral Transduction Particles pLKO.1-puro-CMV-TurboGFP, TRCN0000035952, and TRCN00000229959) or a non-targeting control (MISSION® pLKO.1-puro-CMV-TurboGFP, SHC003), also from Sigma-Aldrich, were added. The cells were incubated overnight to allow transfection. Next, the culture medium was replaced with fresh DMEM containing 5 μg/mL of puromycin (Sigma-Aldrich). This medium was replaced every 72 h until resistant clones grew up. After successful lentiviral transfection, phenotypic selection of FUT8-knockdown clones was achieved via prolonged exposure to Lens culinaris agglutinin lectin (LCA) by supplementing complete medium with 500 μg/mL from Vector Laboratories (Peterborough, UK). Clones were forced to remain in this LCA-containing medium for 7 days, and after this passage, cells were seeded in complete medium without LCA.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!